The theme of the December 6 issue of Newsweek magazine is “Health for Life” and the cover lists several articles about health, but who cares? The real action is in the ads. The “book,” as they say in the business, is 98 pages long and contains 15 full-page ads for pharmaceutical drugs. Promotions include treatments for Alzheimer’s, osteoporosis, chemotherapy-related anemia and Crohn’s disease. There are ads for prescription-strength antacids, nicotine patches, cholesterol fighters and Botox.
Less noticeable are ads for “dietary supplements,” which do not share the sophistication of the pharmaceutical ads. The ads seem low budget and designed to catch the eye of the senior citizen. The high end of this genre promises healthy bones, lower cholesterol and more energy. Moving swiftly downhill, a product promising relief from Irritable Bowel Syndrome screams “Feel the ADVANTAGE!” The ad for “Colon Cleanse” features a photo of a toilet and plunger and touts “a better way to unclog.” For the truly clogged, the same vendor makes “Super Colon Cleanse.”
A pitch for “Mane ’n Tail Hoofmaker” sports images of both horses and a pretty girl. Closer examination reveals the product is a cuticle-enhancing cream, “available at Walgreens.” One full-pager promotes both “Veromax Male Performance Enhancer” and “Sensuest Menopausal Sensual Balance.” The ad makes claims for both products and carries the disclaimer, “These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.”
There were more, but you get the picture — the folks at Newsweek accept ads for everything but snake oil as long as the buyer can get the Benjamins up front.
The most egregious display is a full-page ad in the center of the book, paid for by pharmaceutical giant GlaxoSmithKline. The ad shows three walnut shells labeled “Canada,” “Belize” and “China.” The headline reads: “Take a wild guess where your ‘Canadian’ medicine is actually coming from.”
Smaller copy says, “Drug importation is a game where no one wins. And if new laws pass, drugs that have not been approved by the U.S. Food and Drug Administration (FDA) will have a green light to start pouring into the U.S.” Funny GSK should mention the FDA, since it was FDA that took the arthritis drug Vioxx off the market only after it was shown to have strong links to strokes and heart attacks. It was the same FDA that engaged in character assassination of David Graham, associate director of the Office of Drug Safety after he told Congress FDA is incapable of protecting the public’s interests because it is too cozy with pharmaceutical companies – like GlaxoSmithKline. Next claim?
“The World Health Organization estimates that 10 percent of the world’s drug supply is counterfeit, and as high as 60 percent in some countries.” The 10 percent figure is accurate. For comparison, the W.H.O. says five to eight percent of pharmaceuticals in the U.S. are counterfeit. The line about “some countries” sounds ominous, though. “Some countries” like – Canada?
No, “some countries” like Cambodia. The PR folks at GSK dug up a W.H.O.- referenced study from 1999 which estimated that 60 percent of the anti-malarial drugs then in Cambodia were counterfeit. The outdated, nearly irrelevant number was thrown into the ad as a scare tactic.
“The FDA has said that if Congress opens the floodgates to importation, even the entire U.S. Army would not be big enough to carry out the inspections and take the other steps necessary to protect the public against drugs that are not safe or effective.” This sentence starts with the pharma-cronies at FDA, moves on to the fear-appealing image of “open floodgates” and then invokes the U.S. Army which is, as we know, stretched pretty thin already.
However much GlaxoSmithKline spends to tell you otherwise, drugs imported from Canada are safe. They’re safe because Canadian regulators do a better job of ensuring drug safety than their American counterparts at the Food and Drug Administration and because the Canadians are effective regulators, they don’t let pharmaceutical companies like GSK price-gouge the way the FDA does. That’s why people import drugs from Canada in the first place.
© Mark Floegel, 2004

The Future of NAFTA
I’m just back from Mexico. Not the Mexico of gleaming beaches and gringo-oriented resorts, but poor Mexico, where a decade of the North American Free Trade Agreement has taken a terrible toll.
I visited Mexico City, the largest city in the world, with 25 million inhabitants. Mexico, the country, has 100 million inhabitants, so one of every four people in Mexico lives in Mexico City. It’s like five New York Citys in one place, but because Mexico is prone to earthquakes, few of the buildings are more than three stories. The city ranges out in all directions and is covered in a thick blanket of brown, choking smoke. Housing density is 6.5 people per room.
I spoke with Professor Ross Gandy, a U.S. citizen who has been living in Mexico for decades and teaches at the National University. I’m indebted to him for the statistics on Mexico’s post-NAFTA “prosperity.�
Mexico City has 4.5 million cars, which is probably a record, but it also means 70 percent of the people living there don’t have a car. There is a limited urban train system and small, rickety buses can be seen on every street. Nothing moves very fast and people who live in one part of town and work in another are on the street well before dawn.
Four million people in Mexico City (probably not the same four million that own cars) have no sewage. That means no sewer pipes, no septic tanks, no cesspools, nothing. The odor from tens of thousands of tons of human excrement wafts into the brown cloud of pollution every day. The stink goes up, the fecal coliform goes down. Given that, it’s not surprising that half of Mexico’s water is polluted and unfit to drink.
Two-thirds of Mexico’s industry is located in the Valley of Mexico, where Mexico City is. Oh, and because Mexico City is in a valley, it’s subject to air inversions, which means air can be trapped over the city for days, with all the industrial smoke and traffic exhaust and stench of human shit.
A quarter of the people and two-thirds of the industry are in and around Mexico City because, under NAFTA, small Mexican farmers cannot compete with cheap grains – corn, particularly – flooding in from the U.S., so people move to Mexico City or to the maquiladora region along the U.S. border, looking for factory work.
If a Mexican gets a job in one of these factories, he or she might earn the daily minimum wage of 46 pesos a day (about $4 U.S.). Those that have jobs have to support their relatives, which means half of all Mexicans live on $2 U.S. per day or less.
Unfortunately, this is a problem. The $4 per day Mexican industry pays is uncompetitive with factories in China, which pay 25 cents (U.S.) each day. The challenge for President Vicente Fox and other leading politicians is to figure out how to drive down the minimum wage fast enough to remain competitive, but without touching off a revolution. (Mexican politicians, by the way, are the highest paid on earth. While I was there, Mr. Fox and the legislature were squabbling over how many millions of dollars should be allocated to the annual wardrobe budget for Mr. Fox and his wife, Marta Sahagun.)
Fortunately for Mr. Fox, he has a safety valve – the U.S. border. Millions of Mexico’s most ambitious young people sneak over the U.S. border each year to perform tasks Americans won’t touch. This, in turn, helps U.S. employers keep wages down (often below the federal minimum wage) and helps employers (particularly in the south) prevent employees from organizing unions, all of which moves the U.S. along the road Mexico is traveling.
Legal and illegal Mexicans in the U.S. send back around $13 billion U.S. dollars each years, which means remittances are just behind oil revenue (around $14 billion annually) as Mexico’s leading form of income. (Oil income trails drug income, which is roughly estimated to be $30 billion a year, although much goes into offshore banks.)
Ten years of NAFTA have left Mexico a narcostate that sells her citizens to multinational corporations for as little as possible, a nation in which half the people live in squalor, malnutrition and disease.
© Mark Floegel, 2004